MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Chorea (also see specific diagnoses, Huntingtons disease, etc): Clinical features"

  • 2025 International Congress

    Exploring the Characteristic Features of Speech and Facial Expressions in Patients with Huntington’s Disease Based on Machine Learning

    L. Lu, J. Yin, N. Yan, Y. Huang (Sydney, Australia)

    Objective: This study analyzes the speech and facial  characteristics of Huntington's disease (HD) and explores their relationship with clinical manifestations to develop machine learning models…
  • 2025 International Congress

    Chorea as the initial presentation of Erdheim-Chester disease

    I. Sarac, H. Sarac, S. Basic Kinda, F. Borovecki, N. Henigsberg, L. Lugovi Mihic (Zagreb, Croatia)

    Objective: to describe clinical and radiological findings, and disease progression in a patient with Erdheim-Chester disease (ECD) initially presenting with chorea. Background: ECD is a…
  • 2025 International Congress

    Ataxia, the initial symptom in a patient with Huntington’s Disease and Acquired (non-Wilsonian) Hepatocerebral Degeneration

    V. Montero, N. Valdés, á. Pontoni, P. Salles (Santiago de Chile, Chile)

    Objective: To describe a patient with Huntington disease and acquired (non-Wilsonian) hepatocerebral degeneration (AHD) presenting with ataxia. Background: AHD is a neurological disorder that occurs…
  • 2025 International Congress

    Unraveling NKX2-1-related disorders: clinical, genetic, and neuroimaging insights from a global cohort

    JD. Ortigoza-Escobar, L. Nou-Fontanet, C. Ravelli, S. Balsells Mejia, E. Roman Schiffels, A. Innocenti, B. Villafuerte, A. Salazar, V. Quiroz, A. Sariego Jamardo, G. Bonato, A. Díaz-Gomez, A. Afenjar, C. Vilain, P. Dumke Dasilva, D. Garcia-Navas Nuñez, M. Krygier, MJ. Molnar, L. Milanowski, K. Ounap, M. Pauni, R. Borie, P. Vega, M. Villamil, S. Yilmaz, D. Zádori, M. Zawadzka, TS. Barakat, N. Sebastian, D. Natera Debenito, L. Soliani, CM. de Gusmao, G. Garone, N. Specchio, M. Carecchio, JC. Moreno, F. Magrinelli, D. Ebrahimi-Fakhari, C. Castiglioni, M. Kurian, JN. Carvalho, R. Pons, E. Flamand-Roze, D. Doummar (Barcelona, Spain)

    Objective: To analyze the clinical spectrum, genotype-phenotype correlations, and prognostic factors in NKX2-1-related disorders (NKX2-1-RD) through a multicenter study, providing insights for improved diagnosis and…
  • 2025 International Congress

    Huntington disease in a Patient with Extensive Psychiatric History

    A. Sim, A. Drozdov, D. Carrillo, L. Acosta (El Paso, USA)

    Objective: Huntington's Disease (HD) is an autosomal dominant neurodegenerative disorder resulting from an expansion of CAG trinucleotide repeats in the gene encoding the huntingtin protein.…
  • 2025 International Congress

    Huntington’s Disease Care and Patient Diversity in California, United States

    A. Madera, A. Ogilvie, L. Shammas, M. Tobar, P. Perez, K. Luna, D. Okine, A. Mendizabal (Los Angeles, USA)

    Objective: Describe HD patient demographics and healthcare utilization based on Huntington’s Disease Society of America (HDSA) Center of Excellence (COE) status using the California (CA)…
  • 2025 International Congress

    Correlations of plasma glial fibrillary acidic protein levels with glymphatic system impairment in Huntington’s disease

    JH. Yin, LY. Lu, Q. Yang, Y. Huang (Beijing, China)

    Objective: To investigate whether plasma glial fibrillary acidic protein (GFAP) levels are related to glymphatic system function in Huntington's disease (HD). Background: Plasma GFAP levels has…
  • 2025 International Congress

    Hashimoto Encephalopathy, A Choreiform Presentation

    A. Ouedraogo, MM. Bassirou Adamou, E. Fanorena (Bourges, France)

    Objective: We report the case of a woman with chorea as lonely feature Background: Hashimoto encephalopathy is a rare autoimmune and vasculitis encephalopathy.  The first…
  • 2025 International Congress

    Blood-based somatic CAG repeat expansion and clinical progression in Huntington’s disease patients from Western China

    SR. Zhang, YF. Cheng, CY. Li, HF. Shang (Chengdu, China)

    Objective: To investigate the association between blood-based somatic CAG repeat expansion ratio (SER) and clinical characteristics in Huntington’s disease (HD) patients from Western China. Background:…
  • 2025 International Congress

    Autonomic Nervous System Dysfunction in Patients with Huntington’s Disease: Preliminary Results Using the COMPASS-31 Scale

    J. Patino, S. Zadegan, N. Rocha, E. Furr Stimming (Houston, USA)

    Objective: To characterize dysautonomia-related symptoms in Huntington’s disease (HD) gene expansion carriers (HDGECs). Background: Autonomic nervous system (ANS) dysfunction is a recognized feature of HD…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 23
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley